Biomaterials and Microfluidics for Drug Discovery and Development

Mariana R. Carvalho, Roman Truckenmuller, Rui Luis Reis, Joaquim Miguel Oliveira*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Abstract

Microfluidic devices are now one of the most promising tools to mimic in vivo like conditions, either in normal or disease scenarios, such as tumorigenesis or pathogenesis. Together with the potential of biomaterials, its combination with microfluidics represents the ability to more closely mimic cells' natural microenvironment concerning its three-dimensional (3D) nature and continuous perfusion with nutrients and cells' crosstalk. Due to miniaturization and increased experimental throughput, microfluidics have generated significant interest in the drug discovery and development domain. Herein, the most recent advances in the field of microfluidics for drug discovery are overviewed, and the role of biomaterials in 3D in vitro models and the contribution of organ-on-a-chip technologies highlighted.

Original languageEnglish
Title of host publicationBIOMATERIALS AND MICROFLUIDICS-BASED TISSUE ENGINEERED 3D MODELS
EditorsJM Oliveira, RL Reis
PublisherSpringer
Pages121-135
Number of pages15
Volume1230
ISBN (Electronic)978-3-030-36588-2
ISBN (Print)978-3-030-36587-5
DOIs
Publication statusPublished - 2020

Publication series

SeriesAdvances in Experimental Medicine and Biology
Volume1230
ISSN0065-2598

Keywords

  • 3D models
  • Biomaterials
  • Drug discovery
  • Microfluidics
  • Organ-on-a-chip
  • Cancer
  • ON-A-CHIP
  • EXTRACELLULAR-MATRIX
  • CULTURE MODELS
  • PRODUCTIVITY
  • HYDROGEL
  • REPAIR

Cite this